Allarity Therapeutics shares are trading higher after the company announced that its stockholders' equity is significantly above the $2.5 million minimum required by Nasdaq Listing Rule and will submit a request to the SEC to withdraw Form S-1.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.